Paul Nathan
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Ophthalmology top 0.5%
- Ocular Oncology and Treatments
Papers in
- Oncology 89
- Cancer Immunotherapy and Biomarkers 32
- Cutaneous Melanoma Detection and Management 23
- CAR-T cell therapy research 22
-
- Melanoma and MAPK Pathways 44
- Co-authors
- Dirk Schadendorf (33 shared papers)Caroline Robert (28 shared papers)James Larkin (31 shared papers)Keith T. Flaherty (24 shared papers)Bruce G. MacMillan (13 shared papers)Reinhard Dummer (28 shared papers)Vicky Goh (7 shared papers)Jaspal Juttla (3 shared papers)
- Journals
- Journal of Clinical Oncology (69 papers)Annals of Oncology (24 papers)European Journal of Cancer (9 papers)The Lancet Oncology (8 papers)British Journal of Cancer (6 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Paul Nathan
266 papers receiving 7.6k citations
Paul Nathan's Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 3.0k
- Ophthalmology 567
- Pulmonary and Respiratory Medicine 1.6k
- Cancer Research 733
- Immunology 931
Countries citing papers authored by Paul Nathan
This map shows the geographic impact of Paul Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Nathan more than expected).
Fields of papers citing papers by Paul Nathan
This network shows the impact of papers produced by Paul Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Nathan. The network helps show where Paul Nathan may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Nathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group Hit paper breakdown → | 2012 | 1071 |
| 2 | 2011 | 315 | |
| 3 | Metastatic disease from uveal melanoma: treatment options and future prospects Hit paper breakdown → | 2016 | 289 |
| 4 | 2010 | 229 | |
| 5 | 2016 | 213 | |
| 6 | 2018 | 209 | |
| 7 | 2019 | 189 | |
| 8 | 2016 | 171 | |
| 9 | 2010 | 160 | |
| 10 | 2016 | 157 | |
| 11 | 2012 | 153 | |
| 12 | 2009 | 140 | |
| 13 | 2015 | 118 | |
| 14 | 2010 | 117 | |
| 15 | 1978 | 105 | |
| 16 | 2010 | 93 | |
| 17 | 2021 | 92 | |
| 18 | 2015 | 90 | |
| 19 | 2005 | 87 | |
| 20 | 2011 | 86 |
About Paul Nathan
Paul Nathan is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Surgery, having authored 273 papers that have together received 7.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (55 papers), Melanoma and MAPK Pathways (44 papers), Cancer Immunotherapy and Biomarkers (32 papers), Immunotherapy and Immune Responses (29 papers), Ocular Oncology and Treatments (28 papers), Cancer Genomics and Diagnostics (24 papers), Cutaneous Melanoma Detection and Management (23 papers) and CAR-T cell therapy research (22 papers). The work is most often cited by research in Oncology (3.0k citations), Ophthalmology (567 citations), Pulmonary and Respiratory Medicine (1.6k citations), Cancer Research (733 citations) and Immunology (931 citations). Paul Nathan has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Dirk Schadendorf, Caroline Robert, James Larkin, Keith T. Flaherty, Bruce G. MacMillan, Reinhard Dummer, Vicky Goh, Jaspal Juttla, Anup Vinayan and Claus Garbe. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, The Lancet Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.